{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:51:40Z","timestamp":1789656700603,"version":"4.0.1"},"reference-count":35,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,3,25]]},"DOI":"10.1248\/bpb.b25-00698","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T22:11:06Z","timestamp":1774390266000},"page":"547-556","source":"Crossref","is-referenced-by-count":1,"title":["Role of the H19\/miR-423-5p\/DTX3L Axis in Enhancing the Malignant Phenotype of Nasopharyngeal Carcinoma Cells"],"prefix":"10.1248","volume":"49","author":[{"given":"Li","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunrui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Hu","sequence":"additional","affiliation":[{"name":"Hearing Center, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijia","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Tang LL, Chen YP, Chen CB, <i>et al<\/i>. The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma. <i>Cancer Commun.<\/i>, <b>41<\/b>, 1195\u20131227 (2021).","DOI":"10.1002\/cac2.12218"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) McDowell L, Corry J, Ringash J, Rischin D. Quality of life, toxicity and unmet needs in nasopharyngeal cancer survivors. <i>Front. Oncol.<\/i>, <b>10<\/b>, 930 (2020).","DOI":"10.3389\/fonc.2020.00930"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Lee AWM, Ng WT, Chan JYW, Corry J, M\u00e4kitie A, Mendenhall WM, Rinaldo A, Rodrigo JP, Saba NF, Strojan P, Su\u00e1rez C, Vermorken JB, Yom SS, Ferlito A. Management of locally recurrent nasopharyngeal carcinoma. <i>Cancer Treat. Rev.<\/i>, <b>79<\/b>, 101890 (2019).","DOI":"10.1016\/j.ctrv.2019.101890"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hoeller D, Hecker CM, Dikic I. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. <i>Nat. Rev. Cancer<\/i>, <b>6<\/b>, 776\u2013788 (2006).","DOI":"10.1038\/nrc1994"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Senft D, Qi J, Ronai ZA. Ubiquitin ligases in oncogenic transformation and cancer therapy. <i>Nat. Rev. Cancer<\/i>, <b>18<\/b>, 69\u201388 (2018).","DOI":"10.1038\/nrc.2017.105"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Chen L, Niu W, Zang H, Qiu Y. DTX3L accelerates pancreatic cancer progression <i>via<\/i> FAK\/PI3K\/AKT axis. <i>Biochem. Genet.<\/i>, <b>62<\/b>, 814\u2013830 (2024).","DOI":"10.1007\/s10528-023-10451-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Xu P, Tao X, Zhao C, Huang Q, Chang H, Ban N, Bei Y, Xia X, Shen C, Wang K, Xu L, Wu P, Ren J, Wang D. DTX3L is upregulated in glioma and is associated with glioma progression. <i>Int. J. Mol. Med.<\/i>, <b>40<\/b>, 491\u2013498 (2017).","DOI":"10.3892\/ijmm.2017.3023"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Lin S. DTX3L mediated ubiquitination of cGAS suppresses antitumor immunity in pancreatic cancer. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>681<\/b>, 106\u2013110 (2023).","DOI":"10.1016\/j.bbrc.2023.09.073"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Bachmann SB, Frommel SC, Camicia R, Winkler HC, Santoro R, Hassa PO. DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells. <i>Mol. Cancer<\/i>, <b>13<\/b>, 125 (2014).","DOI":"10.1186\/1476-4598-13-125"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Vela-Rodr\u00edguez C, Lehti\u00f6 L. Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer. <i>Biochem. Soc. Trans.<\/i>, <b>50<\/b>, 1683\u20131692 (2022).","DOI":"10.1042\/BST20220501"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Hu W, Hu Y, Pei Y, Li R, Xu F, Chi X, Mi J, Bergquist J, Lu L, Zhang L, Yang C. Silencing DTX3L inhibits the progression of cervical carcinoma by regulating PI3K\/AKT\/mTOR signaling pathway. <i>Int. J. Mol. Sci.<\/i>, <b>24<\/b>, 861 (2023).","DOI":"10.3390\/ijms24010861"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Chen S, Shen X. Long noncoding RNAs: functions and mechanisms in colon cancer. <i>Mol. Cancer<\/i>, <b>19<\/b>, 167 (2020).","DOI":"10.1186\/s12943-020-01287-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Wang M, Tu Y, Liu C, Cheng H, Zhang M, Li Q. Gambogenic acid inhibits invasion and metastasis of melanoma through regulation of lncRNA MEG3. <i>Biol. Pharm. Bull.<\/i>, <b>46<\/b>, 1385\u20131393 (2023).","DOI":"10.1248\/bpb.b23-00156"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Hashemi M, Moosavi MS, Abed HM, Dehghani M, Aalipour M, Heydari EA, Behroozaghdam M, Entezari M, Salimimoghadam S, Gunduz ES, Taheriazam A, Mirzaei S, Samarghandian S. Long non-coding RNA (lncRNA) H19 in human cancer: from proliferation and metastasis to therapy. <i>Pharmacol. Res.<\/i>, <b>184<\/b>, 106418 (2022).","DOI":"10.1016\/j.phrs.2022.106418"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Alipoor B, Parvar SN, Sabati Z, Ghaedi H, Ghasemi H. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance. <i>Mol. Biol. Rep.<\/i>, <b>47<\/b>, 6357\u20136374 (2020).","DOI":"10.1007\/s11033-020-05695-x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Wang J, Xie S, Yang J, Xiong H, Jia Y, Zhou Y, Chen Y, Ying X, Chen C, Ye C, Wang L, Zhou J. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer <i>via<\/i> autophagy. <i>J. Hematol. Oncol.<\/i>, <b>12<\/b>, 81 (2019).","DOI":"10.1186\/s13045-019-0747-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Zhu H. Silencing long non-coding RNA H19 combined with paclitaxel inhibits nasopharyngeal carcinoma progression. <i>Int. J. Pediatr. Otorhinolaryngol.<\/i>, <b>138<\/b>, 110249 (2020).","DOI":"10.1016\/j.ijporl.2020.110249"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Li X, Lin Y, Yang X, Wu X, He X. Long noncoding RNA H19 regulates EZH2 expression by interacting with miR-630 and promotes cell invasion in nasopharyngeal carcinoma. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>473<\/b>, 913\u2013919 (2016).","DOI":"10.1016\/j.bbrc.2016.03.150"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Mu X, Wang H, Li H. Silencing of long noncoding RNA H19 alleviates pulmonary injury, inflammation, and fibrosis of acute respiratory distress syndrome through regulating the microRNA-423-5p\/FOXA1 axis. <i>Exp. Lung Res.<\/i>, <b>47<\/b>, 183\u2013197 (2021).","DOI":"10.1080\/01902148.2021.1887967"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Lian Y, Xiong F, Yang L, <i>et al<\/i>. Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho\/Rac pathway. <i>J. Exp. Clin. Cancer Res.<\/i>, <b>37<\/b>, 253 (2018).","DOI":"10.1186\/s13046-018-0918-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Jiang R, Niu X, Huang Y, Wang X. \u03b2-Catenin is important for cancer stem cell generation and tumorigenic activity in nasopharyngeal carcinoma. <i>Acta Biochim. Biophys. Sin.<\/i>, <b>48<\/b>, 229\u2013237 (2016).","DOI":"10.1093\/abbs\/gmv134"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Yuan J, Tan L, Yin Z, Zhu W, Tao K, Wang G, Shi W, Gao J. MIR17HG-miR-18a\/19a axis, regulated by interferon regulatory factor-1, promotes gastric cancer metastasis <i>via<\/i> Wnt\/\u03b2-catenin signalling. <i>Cell Death Dis.<\/i>, <b>10<\/b>, 454 (2019).","DOI":"10.1038\/s41419-019-1685-z"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) He J, Bu Y, Li X, Zhang X, Ma L. Tumor-promoting properties of TMEM9A in breast cancer progression <i>via<\/i> activating the Wnt\/\u03b2-catenin signaling pathway. <i>Biol. Pharm. Bull.<\/i>, <b>46<\/b>, 74\u201385 (2023).","DOI":"10.1248\/bpb.b22-00602"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Jing W, Wang G, Cui Z, Xiong G, Jiang X, Li Y, Li W, Han B, Chen S, Shi B. FGFR3 destabilizes PD-L1 <i>via<\/i> NEDD4 to control T-cell-mediated bladder cancer immune surveillance. <i>Cancer Res.<\/i>, <b>82<\/b>, 114\u2013129 (2022).","DOI":"10.1158\/0008-5472.CAN-21-2362"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Wang X, Tokheim C, Gu SS, <i>et al<\/i>. <i>In vivo<\/i> CRISPR screens identify the E3 ligase <i>Cop1<\/i> as a modulator of macrophage infiltration and cancer immunotherapy target. <i>Cell<\/i>, <b>184<\/b>, 5357\u201374.e22 (2021).","DOI":"10.1016\/j.cell.2021.09.006"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Zhou Z, Zheng K, Zhou S, Yang Y, Chen J, Jin X. E3 ubiquitin ligases in nasopharyngeal carcinoma and implications for therapies. <i>J. Mol. Med.<\/i>, <b>101<\/b>, 1543\u20131565 (2023).","DOI":"10.1007\/s00109-023-02376-7"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Vall\u00e9e A, Lecarpentier Y. Crosstalk between peroxisome proliferator-activated receptor gamma and the canonical WNT\/\u03b2-catenin pathway in chronic inflammation and oxidative stress during carcinogenesis. <i>Front. Immunol.<\/i>, <b>9<\/b>, 745 (2018).","DOI":"10.3389\/fimmu.2018.00745"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Zhang J, Xie T, Zhong X, Jiang HL, Li R, Wang BY, Huang XT, Cen BH, Yuan YW. Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt\/\u03b2-catenin signaling pathway. <i>Aging<\/i>, <b>12<\/b>, 5423\u20135438 (2020).","DOI":"10.18632\/aging.102968"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Yang XZ, Chen XM, Zeng LS, Deng J, Ma L, Jin C, Wang R, Wang MH, Wen YF, Wu XL, Wang HY, Cui SZ. Rab1A promotes cancer metastasis and radioresistance through activating GSK-3\u03b2\/Wnt\/\u03b2-catenin signaling in nasopharyngeal carcinoma. <i>Aging<\/i>, <b>12<\/b>, 20380\u201320395 (2020).","DOI":"10.18632\/aging.103829"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Ji Y, Wang M, Li X, Cui F. The long noncoding RNA NEAT1 targets miR-34a-5p and drives nasopharyngeal carcinoma progression <i>via<\/i> Wnt\/\u03b2-catenin signaling. <i>Yonsei Med. J.<\/i>, <b>60<\/b>, 336\u2013345 (2019).","DOI":"10.3349\/ymj.2019.60.4.336"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Zhang L, Dang Y, Wang Y, Fan X. Nucleolar and spindle-associated protein 1 accelerates cellular proliferation and invasion in nasopharyngeal carcinoma by potentiating Wnt\/\u03b2-catenin signaling <i>via<\/i> modulation of GSK-3\u03b2. <i>J. Bioenerg. Biomembr.<\/i>, <b>52<\/b>, 441\u2013451 (2020).","DOI":"10.1007\/s10863-020-09860-6"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Li X, Luo S, Zhang J, Yuan Y, Jiang W, Zhu H, Ding X, Zhan L, Wu H, Xie Y, Song R, Pan Z, Lu Y. lncRNA H19 alleviated myocardial I\/RI <i>via<\/i> suppressing miR-877-3p\/Bcl-2-mediated mitochondrial apoptosis. <i>Mol. Ther. Nucleic Acids<\/i>, <b>17<\/b>, 297\u2013309 (2019).","DOI":"10.1016\/j.omtn.2019.05.031"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Yang W, Ning N, Jin X. The lncRNA H19 promotes cell proliferation by competitively binding to miR-200a and derepressing \u03b2-catenin expression in colorectal cancer. <i>BioMed Res. Int.<\/i>, <b>2017<\/b>, 2767484 (2017).","DOI":"10.1155\/2017\/2767484"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Ye Y, Lin M, Zhou G, Wang W, Yao Y, Su Y, Qi J, Zheng Y, Zhong C, Chen X, Huang M, Lu Y. Fuyuan decoction prevents nasopharyngeal carcinoma metastasis by inhibiting circulating tumor cells\/endothelial cells interplay and enhancing anti-cancer immune response. <i>Front. Pharmacol.<\/i>, <b>15<\/b>, 1355650 (2024).","DOI":"10.3389\/fphar.2024.1355650"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Thang ND, Yajima I, Kumasaka MY, Iida M, Suzuki T, Kato M. Deltex-3-like (DTX3L) stimulates metastasis of melanoma through FAK\/PI3K\/AKT but not MEK\/ERK pathway. <i>Oncotarget<\/i>, <b>6<\/b>, 14290\u201314299 (2015).","DOI":"10.18632\/oncotarget.3742"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/3\/49_b25-00698\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T03:22:36Z","timestamp":1774668156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/3\/49_b25-00698\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00698","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"article-number":"b25-00698"}}